Gene Silencing  Market Report

Global Gene Silencing Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：202
  • REPORT CODE：GMM769096
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Gene Silencing market report explains the definition, types, applications, major countries, and major players of the Gene Silencing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Merck Group

    • Silence Therapeutics plc

    • Idera Pharmaceuticals

    • Alnylam Pharmaceuticals

    • RXi Pharmaceuticals

    • Eli Lilly (Dicerna Pharmaceuticals)

    • Arrowhead Pharmaceuticals

    • Benitec Biopharma

    • Monsanto (Bayer AG)

    By Type:

    • Transcriptional

    • Post-transcriptional

    • Meiotic

    By End-User:

    • Cancer Treatment

    • Neurological Diseases Treatment

    • Scar Treatment

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Gene Silencing Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Gene Silencing Outlook to 2028- Original Forecasts

    • 2.2 Gene Silencing Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Gene Silencing Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Gene Silencing Market- Recent Developments

    • 6.1 Gene Silencing Market News and Developments

    • 6.2 Gene Silencing Market Deals Landscape

    7 Gene Silencing Raw Materials and Cost Structure Analysis

    • 7.1 Gene Silencing Key Raw Materials

    • 7.2 Gene Silencing Price Trend of Key Raw Materials

    • 7.3 Gene Silencing Key Suppliers of Raw Materials

    • 7.4 Gene Silencing Market Concentration Rate of Raw Materials

    • 7.5 Gene Silencing Cost Structure Analysis

      • 7.5.1 Gene Silencing Raw Materials Analysis

      • 7.5.2 Gene Silencing Labor Cost Analysis

      • 7.5.3 Gene Silencing Manufacturing Expenses Analysis

    8 Global Gene Silencing Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Gene Silencing Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Gene Silencing Export by Region (Top 10 Countries) (2017-2028)

    9 Global Gene Silencing Market Outlook by Types and Applications to 2022

    • 9.1 Global Gene Silencing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Transcriptional Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Post-transcriptional Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Meiotic Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gene Silencing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Neurological Diseases Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Scar Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Gene Silencing Market Analysis and Outlook till 2022

    • 10.1 Global Gene Silencing Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Gene Silencing Consumption (2017-2022)

      • 10.2.2 Canada Gene Silencing Consumption (2017-2022)

      • 10.2.3 Mexico Gene Silencing Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Gene Silencing Consumption (2017-2022)

      • 10.3.2 UK Gene Silencing Consumption (2017-2022)

      • 10.3.3 Spain Gene Silencing Consumption (2017-2022)

      • 10.3.4 Belgium Gene Silencing Consumption (2017-2022)

      • 10.3.5 France Gene Silencing Consumption (2017-2022)

      • 10.3.6 Italy Gene Silencing Consumption (2017-2022)

      • 10.3.7 Denmark Gene Silencing Consumption (2017-2022)

      • 10.3.8 Finland Gene Silencing Consumption (2017-2022)

      • 10.3.9 Norway Gene Silencing Consumption (2017-2022)

      • 10.3.10 Sweden Gene Silencing Consumption (2017-2022)

      • 10.3.11 Poland Gene Silencing Consumption (2017-2022)

      • 10.3.12 Russia Gene Silencing Consumption (2017-2022)

      • 10.3.13 Turkey Gene Silencing Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Gene Silencing Consumption (2017-2022)

      • 10.4.2 Japan Gene Silencing Consumption (2017-2022)

      • 10.4.3 India Gene Silencing Consumption (2017-2022)

      • 10.4.4 South Korea Gene Silencing Consumption (2017-2022)

      • 10.4.5 Pakistan Gene Silencing Consumption (2017-2022)

      • 10.4.6 Bangladesh Gene Silencing Consumption (2017-2022)

      • 10.4.7 Indonesia Gene Silencing Consumption (2017-2022)

      • 10.4.8 Thailand Gene Silencing Consumption (2017-2022)

      • 10.4.9 Singapore Gene Silencing Consumption (2017-2022)

      • 10.4.10 Malaysia Gene Silencing Consumption (2017-2022)

      • 10.4.11 Philippines Gene Silencing Consumption (2017-2022)

      • 10.4.12 Vietnam Gene Silencing Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Gene Silencing Consumption (2017-2022)

      • 10.5.2 Colombia Gene Silencing Consumption (2017-2022)

      • 10.5.3 Chile Gene Silencing Consumption (2017-2022)

      • 10.5.4 Argentina Gene Silencing Consumption (2017-2022)

      • 10.5.5 Venezuela Gene Silencing Consumption (2017-2022)

      • 10.5.6 Peru Gene Silencing Consumption (2017-2022)

      • 10.5.7 Puerto Rico Gene Silencing Consumption (2017-2022)

      • 10.5.8 Ecuador Gene Silencing Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Gene Silencing Consumption (2017-2022)

      • 10.6.2 Kuwait Gene Silencing Consumption (2017-2022)

      • 10.6.3 Oman Gene Silencing Consumption (2017-2022)

      • 10.6.4 Qatar Gene Silencing Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Gene Silencing Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Gene Silencing Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Gene Silencing Consumption (2017-2022)

      • 10.7.2 South Africa Gene Silencing Consumption (2017-2022)

      • 10.7.3 Egypt Gene Silencing Consumption (2017-2022)

      • 10.7.4 Algeria Gene Silencing Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Gene Silencing Consumption (2017-2022)

      • 10.8.2 New Zealand Gene Silencing Consumption (2017-2022)

    11 Global Gene Silencing Competitive Analysis

    • 11.1 Merck Group

      • 11.1.1 Merck Group Company Details

      • 11.1.2 Merck Group Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Merck Group Gene Silencing Main Business and Markets Served

      • 11.1.4 Merck Group Gene Silencing Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Silence Therapeutics plc

      • 11.2.1 Silence Therapeutics plc Company Details

      • 11.2.2 Silence Therapeutics plc Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Silence Therapeutics plc Gene Silencing Main Business and Markets Served

      • 11.2.4 Silence Therapeutics plc Gene Silencing Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Idera Pharmaceuticals

      • 11.3.1 Idera Pharmaceuticals Company Details

      • 11.3.2 Idera Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Idera Pharmaceuticals Gene Silencing Main Business and Markets Served

      • 11.3.4 Idera Pharmaceuticals Gene Silencing Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Alnylam Pharmaceuticals

      • 11.4.1 Alnylam Pharmaceuticals Company Details

      • 11.4.2 Alnylam Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Alnylam Pharmaceuticals Gene Silencing Main Business and Markets Served

      • 11.4.4 Alnylam Pharmaceuticals Gene Silencing Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 RXi Pharmaceuticals

      • 11.5.1 RXi Pharmaceuticals Company Details

      • 11.5.2 RXi Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 RXi Pharmaceuticals Gene Silencing Main Business and Markets Served

      • 11.5.4 RXi Pharmaceuticals Gene Silencing Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Eli Lilly (Dicerna Pharmaceuticals)

      • 11.6.1 Eli Lilly (Dicerna Pharmaceuticals) Company Details

      • 11.6.2 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Main Business and Markets Served

      • 11.6.4 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Arrowhead Pharmaceuticals

      • 11.7.1 Arrowhead Pharmaceuticals Company Details

      • 11.7.2 Arrowhead Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Arrowhead Pharmaceuticals Gene Silencing Main Business and Markets Served

      • 11.7.4 Arrowhead Pharmaceuticals Gene Silencing Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Benitec Biopharma

      • 11.8.1 Benitec Biopharma Company Details

      • 11.8.2 Benitec Biopharma Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Benitec Biopharma Gene Silencing Main Business and Markets Served

      • 11.8.4 Benitec Biopharma Gene Silencing Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Monsanto (Bayer AG)

      • 11.9.1 Monsanto (Bayer AG) Company Details

      • 11.9.2 Monsanto (Bayer AG) Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Monsanto (Bayer AG) Gene Silencing Main Business and Markets Served

      • 11.9.4 Monsanto (Bayer AG) Gene Silencing Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Gene Silencing Market Outlook by Types and Applications to 2028

    • 12.1 Global Gene Silencing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Transcriptional Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Post-transcriptional Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Meiotic Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Gene Silencing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Neurological Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Scar Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Gene Silencing Market Analysis and Outlook to 2028

    • 13.1 Global Gene Silencing Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Gene Silencing Consumption Forecast (2022-2028)

      • 13.2.2 Canada Gene Silencing Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Gene Silencing Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.2 UK Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.3 Spain Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.5 France Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.6 Italy Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.8 Finland Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.9 Norway Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.11 Poland Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.12 Russia Gene Silencing Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Gene Silencing Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.2 Japan Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.3 India Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Gene Silencing Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Gene Silencing Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.3 Chile Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.6 Peru Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Gene Silencing Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Gene Silencing Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Gene Silencing Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Gene Silencing Consumption Forecast (2022-2028)

      • 13.6.3 Oman Gene Silencing Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Gene Silencing Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Gene Silencing Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Gene Silencing Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Gene Silencing Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Gene Silencing Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Gene Silencing Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Gene Silencing Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Gene Silencing Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Gene Silencing Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Gene Silencing

    • Figure of Gene Silencing Picture

    • Table Global Gene Silencing Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Gene Silencing Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Transcriptional Consumption and Growth Rate (2017-2022)

    • Figure Global Post-transcriptional Consumption and Growth Rate (2017-2022)

    • Figure Global Meiotic Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Diseases Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Scar Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Gene Silencing Consumption by Country (2017-2022)

    • Table North America Gene Silencing Consumption by Country (2017-2022)

    • Figure United States Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Canada Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Mexico Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table Europe Gene Silencing Consumption by Country (2017-2022)

    • Figure Germany Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure UK Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Spain Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Belgium Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure France Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Italy Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Denmark Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Finland Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Norway Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Sweden Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Poland Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Russia Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Turkey Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table APAC Gene Silencing Consumption by Country (2017-2022)

    • Figure China Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Japan Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure India Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Thailand Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Singapore Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Philippines Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table South America Gene Silencing Consumption by Country (2017-2022)

    • Figure Brazil Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Colombia Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Chile Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Argentina Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Peru Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table GCC Gene Silencing Consumption by Country (2017-2022)

    • Figure Bahrain Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Oman Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Qatar Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table Africa Gene Silencing Consumption by Country (2017-2022)

    • Figure Nigeria Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure South Africa Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Egypt Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure Algeria Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table Oceania Gene Silencing Consumption by Country (2017-2022)

    • Figure Australia Gene Silencing Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Gene Silencing Consumption and Growth Rate (2017-2022)

    • Table Merck Group Company Details

    • Table Merck Group Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Group Gene Silencing Main Business and Markets Served

    • Table Merck Group Gene Silencing Product Portfolio

    • Table Silence Therapeutics plc Company Details

    • Table Silence Therapeutics plc Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silence Therapeutics plc Gene Silencing Main Business and Markets Served

    • Table Silence Therapeutics plc Gene Silencing Product Portfolio

    • Table Idera Pharmaceuticals Company Details

    • Table Idera Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Idera Pharmaceuticals Gene Silencing Main Business and Markets Served

    • Table Idera Pharmaceuticals Gene Silencing Product Portfolio

    • Table Alnylam Pharmaceuticals Company Details

    • Table Alnylam Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Gene Silencing Main Business and Markets Served

    • Table Alnylam Pharmaceuticals Gene Silencing Product Portfolio

    • Table RXi Pharmaceuticals Company Details

    • Table RXi Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table RXi Pharmaceuticals Gene Silencing Main Business and Markets Served

    • Table RXi Pharmaceuticals Gene Silencing Product Portfolio

    • Table Eli Lilly (Dicerna Pharmaceuticals) Company Details

    • Table Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Main Business and Markets Served

    • Table Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product Portfolio

    • Table Arrowhead Pharmaceuticals Company Details

    • Table Arrowhead Pharmaceuticals Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arrowhead Pharmaceuticals Gene Silencing Main Business and Markets Served

    • Table Arrowhead Pharmaceuticals Gene Silencing Product Portfolio

    • Table Benitec Biopharma Company Details

    • Table Benitec Biopharma Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Benitec Biopharma Gene Silencing Main Business and Markets Served

    • Table Benitec Biopharma Gene Silencing Product Portfolio

    • Table Monsanto (Bayer AG) Company Details

    • Table Monsanto (Bayer AG) Gene Silencing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Monsanto (Bayer AG) Gene Silencing Main Business and Markets Served

    • Table Monsanto (Bayer AG) Gene Silencing Product Portfolio

    • Figure Global Transcriptional Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Post-transcriptional Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meiotic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurological Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Scar Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gene Silencing Consumption Forecast by Country (2022-2028)

    • Table North America Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure United States Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure Germany Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure China Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure Brazil Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Gene Silencing Consumption Forecast by Country (2022-2028)

    • Figure Australia Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Gene Silencing Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US